Although requiring the generation of two products for each individual, this study showed that the inclusion of the CD28 signaling motif supported superior activation, proliferation, and effector function of CAR-T cells in patients with CD19+ Non-Hodgkin lymphoma (NHL) (13). This evidence concerns the gene CD28 and non-Hodgkin lymphoma.